CBDNewsBreaks – No Borders, Inc. (NBDR) Files First Blockchain Provisional Patent for its CBD LabChain Platform

February 4, 2020 12:04:10

No Borders (OTC: NBDR) today announced that it has successfully filed the first blockchain provisional patent for its CBD LabChain platform. According to the update, the provisional patent, registered as Application Serial #62969531 with the USPTO on Feb. 3, 2020, now allows NBDR’s CBD LabChain platform to operate with “Patent Pending” identifiers and messaging. This marks the very first Patent Pending achievement for the No Borders family of companies and supports the company’s mission to impact shareholder value by building a valuable portfolio of IP assets. “It has been a long road to get to this day and I am stoked to share our first patent filing with the world! This filing marks a milestone for our Company and our amazing shareholders,” No Borders, Inc. CEO Joseph Snyder said in the news release. “We have consistently stated that No Borders is committed to building and owning a strong IP portfolio and I am proud that we have multiple Trademark approvals, in addition to this initial Patent filing. A giant thank you to both Chris Brown and the No Borders Labs teams as well as Andrew Coldicutt and Keith Alan Miller for the legal work they put in to get our filings prepped and really doing an amazing job on behalf of No Borders, Inc.”

To view the full press release, visit http://cnw.fm/EuGR8

About No Borders Inc.

No Borders, Inc. (OTC: NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority and Intellectual Property ownership across its portfolio of assets. The Company’s portfolio of brands includes:

  • No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets. (NoBordersNaturals.com)
  • No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency (NoBordersLabs.com).
  • CBDLabChain.com a powerful, Patent Pending tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate Of Authority (COA) on a blockchain technology platform.
  • No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (MediDentSupplies.com).

No Borders is headquartered in Arizona with resources in the U.S., South America, Asia and Europe. For more information, visit the Company’s website at www.NBDR.co.

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR

About CBDWire

CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CBDW? Ask our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.